APA Цитирование

Zhou, Y., Liang, C., Xue, F., Chen, W., Zhi, X., Feng, X., . . . Liang, T. (2015). Salinomycin decreases doxorubicin resistance in hepatocellular carcinoma cells by inhibiting the β-catenin/TCF complex association via FOXO3a activation. Oncotarget.

Chicago-стиль цитирования

Zhou, Yue, Chao Liang, Fei Xue, Wei Chen, Xiao Zhi, Xinhua Feng, Xueli Bai, and Tingbo Liang. "Salinomycin Decreases Doxorubicin Resistance in Hepatocellular Carcinoma Cells By Inhibiting the β-catenin/TCF Complex Association Via FOXO3a Activation." Oncotarget 2015.

MLA-цитирование

Zhou, Yue, et al. "Salinomycin Decreases Doxorubicin Resistance in Hepatocellular Carcinoma Cells By Inhibiting the β-catenin/TCF Complex Association Via FOXO3a Activation." Oncotarget 2015.

Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.